Aripiprazole
Brand name: Aripiprazole
Rank #49 of 500 drugs by total cost
$373.1M
Total Cost
1,494,971
Total Claims
$373.1M
Total Cost
34,750
Prescribers
$250
Cost per Claim
170,006
Beneficiaries
1,947,280
30-Day Fills
$11K
Avg Cost/Provider
43
Avg Claims/Provider
About Aripiprazole
Aripiprazole (sold as Aripiprazole) was prescribed 1,494,971 times by 34,750 Medicare Part D providers in 2023, costing the program $373.1M. At $250 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 46 | Linagliptin (Tradjenta) | $403.8M | 519,439 |
| 47 | Macitentan (Opsumit) | $394.6M | 30,889 |
| 48 | Insulin Detemir (Levemir Flexpen) | $376.5M | 548,216 |
| 49 | Aripiprazole (Aripiprazole) | $373.1M | 1,494,971 |
| 50 | Apalutamide (Erleada) | $369.2M | 24,956 |
| 51 | Secukinumab (Cosentyx Sensoready (2 Pens)) | $347.7M | 45,496 |
| 52 | Upadacitinib (Rinvoq) | $346.0M | 51,469 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology